About Cifofem
Citofem provides a modern alternative to the pap test which was developed in 1943. Citofem, along with other liquid cytology tests, has begun the modernization of cervical cancer diagnosis by providing a test that will present a greater number of cells in a laminar or sheet-like fashion, so that the technologist can provide a much more efficient and precise diagnosis.
Why Cifofem ?
- 100% of the collected sample sent to the lab for processing.
- High quantity of endocervix-specific cells collected.
- Fast processing that can be scaled for efficiency.
- Removes interfering substances in the sample.
- Allows for multiple tests to be run off a single sample.
- Allows for significant cost savings to the lab.
- Requires no expensive processing equipment .
- Pathologists and cytotechnologists will enjoy a quick and more efficient diagnosis.
In processing, the samples are concentrated, preserving the cells and removing many of the contaminants, such as mucus and inflammation. Then the concentrated cells are removed and preserved, requiring a small amount of the collected cells for initial testing. This allows for multiple tests to be run of a single collection sample. 
Advanced screening techniques ranging from cell collection to analysis make Citofem® a great choice for modern cervical cancer screening. 
In the fight against cervical cancer, there are many clear advantages to using Liquid Based Cytology (LBC) as the primary screening tool. LBC is quality and affordable product which is easy to use for for patients, medical professionals and laboratory workers. The testing materials, combined with no ancillary fees in terms of additional equipment requirements, make Citofem an affordable choice.
